Accepted 2025-11-25
This weight regain occurs because the medications appetite suppression effects wear off, hunger and cravings return, and without ongoing treatment, the physiological factors that contributed to weight gain resume
Over the first 20 weeks of treatment, patients lost an average of 10.6 percent of their baseline body weight as they moved through their titration steps (Source: STEP 4 Trial, Rubino et al., JAMA 2021)
Can berberine be used as an adjunct or attack treatment in an adult patient with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, who is already on tirzepatide (glucagon-like peptide-1 (GLP-1) receptor agonist) therapy?
Bodybuilders prefer to combine the benefits of both compounds
A new analysis from the CEA projects substantial long-term savings from future drug launches, Medicaid spending reductions, and direct-to-consumer pricing initiatives